Cargando…

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited

BACKGROUND: Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disorder with typical onset in the 5(th)- 6(th) decade of life. The hypothesis of an autoimmune origin of ALS receives less attention today, but immunological phenomena still seem to be involved and mechanisms such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kollewe, Katja, Wurster, Ulrich, Sinzenich, Thomas, Körner, Sonja, Dengler, Reinhard, Mohammadi, Bahram, Petri, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397083/ https://www.ncbi.nlm.nih.gov/pubmed/25875836 http://dx.doi.org/10.1371/journal.pone.0125339

Ejemplares similares

Magnetic Resonance Imaging in Amyotrophic Lateral Sclerosis
por: Kollewe, Katja, et al.
Publicado: (2012)

Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort
por: Körner, Sonja, et al.
Publicado: (2015)

Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options
por: Körner, Sonja, et al.
Publicado: (2013)

Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic
por: von Neuhoff, Nils, et al.
Publicado: (2012)

Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study
por: Kopitzki, Klaus, et al.
Publicado: (2016)

Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis
por: Cardenas-Blanco, Arturo, et al.
Publicado: (2016)

Structural and functional hallmarks of amyotrophic lateral sclerosis progression in motor- and memory-related brain regions
por: Stoppel, Christian Michael, et al.
Publicado: (2014)

Global Hippocampal Volume Reductions and Local CA1 Shape Deformations in Amyotrophic Lateral Sclerosis
por: Machts, Judith, et al.
Publicado: (2018)

Memory deficits in amyotrophic lateral sclerosis are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment
por: Machts, Judith, et al.
Publicado: (2014)

Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression—a multicenter study
por: Hertel, Nora, et al.
Publicado: (2022)

Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness
por: Thorns, Johannes, et al.
Publicado: (2013)

Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis
por: Seer, Caroline, et al.
Publicado: (2015)

The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea
por: Vogt, Susanne, et al.
Publicado: (2019)

Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
por: Keil, Carsten, et al.
Publicado: (2012)

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
por: Grosskreutz, Julian, et al.
Publicado: (2006)

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
por: Morrison, Brett, et al.
Publicado: (2012)

Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population
por: Korner, Sonja, et al.
Publicado: (2019)

A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis
por: Xu, Xiaohua, et al.
Publicado: (2015)

Sporadic Amyotrophic Lateral Sclerosis Due to a FUS P525L Mutation with Asymmetric Muscle Weakness and Anti-ganglioside Antibodies
por: Tanemoto, Masanobu, et al.
Publicado: (2021)

A Computational Study of Executive Dysfunction in Amyotrophic Lateral Sclerosis
por: Steinke, Alexander, et al.
Publicado: (2020)

Cognitive Performance of Patients with Adult 5q-Spinal Muscular Atrophy and with Amyotrophic Lateral Sclerosis
por: Osmanovic, Alma, et al.
Publicado: (2020)

Widespread temporo-occipital lobe dysfunction in amyotrophic lateral sclerosis
por: Loewe, Kristian, et al.
Publicado: (2017)

Disrupted neuronal trafficking in amyotrophic lateral sclerosis
por: Burk, Katja, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Therapeutic Potential of Mesenchymal Stromal Cells and MSC Conditioned Medium in Amyotrophic Lateral Sclerosis (ALS) - In Vitro Evidence from Primary Motor Neuron Cultures, NSC-34 Cells, Astrocytes and Microglia
por: Sun, Hui, et al.
Publicado: (2013)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany
por: Schönfelder, Erik, et al.
Publicado: (2020)

Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2014)

Frontotemporal dementia and amyotrophic lateral sclerosis: revisiting one of the first case reports with neuropathology examination
por: Nitrini, Ricardo
Publicado: (2014)

The Fragile X Protein Family in Amyotrophic Lateral Sclerosis
por: Mueller, Sarah, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Amyotrophic lateral sclerosis in a patient who recovered from Miller Fisher Syndrome: The role of GQ1b antibody revisited
por: Repajic, Michael, et al.
Publicado: (2021)

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
por: Dupuis, Luc, et al.
Publicado: (2012)

The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis
por: Peters, Sebastian, et al.
Publicado: (2017)

Antibody Response to HML‐2 May Be Protective in Amyotrophic Lateral Sclerosis
por: Garcia‐Montojo, Marta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_amlur5mjufdlu71hvrgvv4s013